Presbyopia Completed Phase 2 Trials for Brimonidine (DB00484)

Also known as: Presbyopias

IndicationStatusPhase
DBCOND0001183 (Presbyopia)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04774237Safety and Efficacy Study of BRIMOCHOLâ„¢, BRIMOCHOLâ„¢ F, and Carbachol in Subjects With Emmetropic Phakic and Pseudophakic PresbyopiaTreatment